| dbo:abstract
|
- La instalación dedicada a la producción de isótopos MAPLE (Multipurpose Applied Physics Lattice Experiment) fue un proyecto que llevaron a cabo AECL y . El mismo comprendía dos reactores nucleares idénticos, así como las instalaciones necesarias para el procesado de isótopos. El objetivo era que en funcionamiento, MAPLE fuera capaz de producir la mayor parte de los isótopos de uso médico mundiales, especialmente Molibdeno-99, Cobalto-60 médico y Iodo-131 y -125. En 1999 se obtuvo una licencia para operar el reactor MAPLE 1, y el reactor fue puesto en estado crítico por primera vez. Sin embargo, una serie de problemas de diseño del reactor detectados durante la puesta en marcha, incluyendo la medición de un coeficiente de realimentación de potencia positivo, hicieron que el proyecto fuera cancelado en el 2008. (es)
- The Multipurpose Applied Physics Lattice Experiment (MAPLE), later renamed MDS Medical Isotope Reactors (MMIR), was a dedicated isotope-production facility built by AECL and MDS Nordion. It was intended to include two identical reactors, as well as the isotope-processing facilities necessary to produce a large portion of the world's medical isotopes, especially molybdenum-99, medical cobalt-60, xenon-133, iodine-131 and iodine-125. An operational license for the MAPLE 1 reactor was granted in 1999, and the reactor went critical for the first time soon after. However, problems with the reactor, most notably a positive power co-efficient of reactivity, led to the cancellation of the project in 2008. (en)
|
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 10339 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- The Multipurpose Applied Physics Lattice Experiment (MAPLE), later renamed MDS Medical Isotope Reactors (MMIR), was a dedicated isotope-production facility built by AECL and MDS Nordion. It was intended to include two identical reactors, as well as the isotope-processing facilities necessary to produce a large portion of the world's medical isotopes, especially molybdenum-99, medical cobalt-60, xenon-133, iodine-131 and iodine-125. An operational license for the MAPLE 1 reactor was granted in 1999, and the reactor went critical for the first time soon after. However, problems with the reactor, most notably a positive power co-efficient of reactivity, led to the cancellation of the project in 2008. (en)
- La instalación dedicada a la producción de isótopos MAPLE (Multipurpose Applied Physics Lattice Experiment) fue un proyecto que llevaron a cabo AECL y . El mismo comprendía dos reactores nucleares idénticos, así como las instalaciones necesarias para el procesado de isótopos. El objetivo era que en funcionamiento, MAPLE fuera capaz de producir la mayor parte de los isótopos de uso médico mundiales, especialmente Molibdeno-99, Cobalto-60 médico y Iodo-131 y -125. (es)
|
| rdfs:label
|
- MAPLE (es)
- Multipurpose Applied Physics Lattice Experiment (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
